INDP

Indaptus Therapeutics, Inc. - Common Stock (INDP)

About Indaptus Therapeutics, Inc. - Common Stock (INDP)

Indaptus Therapeutics, Inc. is a clinical biotechnology company. The firm engages in the development of a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It created patented treatment methods and associated patented compositions for attenuation and killing of non-pathogenic, Gram-negative bacteria. The company was founded by Michael James Newman on February 24, 2021 and is headquartered in New York, NY.

Details

Daily high

$2.04

Daily low

$1.82

Price at open

$1.99

52 Week High

$19.91

52 Week Low

$1.51

Market cap

4.2M

Dividend yield

0.00%

Volume

45,656

Avg. volume

73,081

P/E ratio

-.08

Indaptus Therapeutics, Inc. - Common Stock News